We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
–
AUM
$787M
AUM Growth
+$80.8M
Cap. Flow
+$26.5M
Cap. Flow %
3.37%
Top 10 Hldgs %
26.98%
Holding
498
New
39
Increased
268
Reduced
136
Closed
31

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$2.01M
2
MSFT icon
Microsoft
MSFT
+$1.78M
3
ETN icon
Eaton
ETN
+$1.18M
4
DHR icon
Danaher
DHR
+$1.12M
5
HBAN icon
Huntington Bancshares
HBAN
+$1.09M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.97M
2
VOOG icon
Vanguard S&P 500 Growth ETF
VOOG
+$1.15M
3
VOOV icon
Vanguard S&P 500 Value ETF
VOOV
+$897K
4
XEC
CIMAREX ENERGY CO
XEC
+$886K
5
ALXN
Alexion Pharmaceuticals
ALXN
+$822K

Sector Composition

Rank Sector Weight
1 Technology 14.98%
2 Financials 12.65%
3 Healthcare 10.27%
4 Industrials 8.01%
5 Consumer Discretionary 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACN icon
76
Accenture
ACN
$107B
$2.35M 0.3%
11,140
-681
-6% -$133K
AMP icon
77
Ameriprise Financial
AMP
$48.1B
$2.32M 0.29%
13,907
-699
-5% -$108K
KMB icon
78
Kimberly-Clark
KMB
$37.4B
$2.3M 0.29%
16,741
-68
-0.4% -$9.2K
QQQ icon
79
Invesco QQQ Trust
QQQ
$438B
$2.21M 0.28%
10,369
+416
+4% +$83.3K
PSX icon
80
Phillips 66
PSX
$83.9B
$2.19M 0.28%
19,630
-244
-1% -$27.4K
MRSH
81
Marsh
MRSH
$94.5B
$2.15M 0.27%
19,273
+749
+4% +$78.2K
TMO icon
82
Thermo Fisher Scientific
TMO
$215B
$2.14M 0.27%
6,592
+138
+2% +$41.8K
MCHP icon
83
Microchip Technology
MCHP
$38.9B
$2.12M 0.27%
40,544
+1,132
+3% +$54.7K
LEN icon
84
Lennar Class A
LEN
$20.5B
$2.06M 0.26%
38,224
+1,666
+5% +$95K
WEC icon
85
WEC Energy
WEC
$36.6B
$2.05M 0.26%
22,214
+982
+5% +$89.5K
VUG icon
86
Vanguard Growth ETF
VUG
$213B
$2.05M 0.26%
67,398
-600
-0.9% -$17.3K
COF icon
87
Capital One
COF
$130B
$2.03M 0.26%
19,744
-1,202
-6% -$116K
IWN icon
88
iShares Russell 2000 Value ETF
IWN
$14.4B
$2.01M 0.26%
15,655
+873
+6% +$108K
VOT icon
89
Vanguard Mid-Cap Growth ETF
VOT
$18.9B
$2M 0.25%
12,629
– –
CVS icon
90
CVS Health
CVS
$138B
$1.95M 0.25%
26,297
-1,607
-6% -$113K
PNC icon
91
PNC Financial Services
PNC
$99.5B
$1.92M 0.24%
12,015
+724
+6% +$109K
HCA icon
92
HCA Healthcare
HCA
$91.9B
$1.91M 0.24%
12,912
-1,113
-8% -$149K
LOW icon
93
Lowe's Companies
LOW
$122B
$1.89M 0.24%
15,758
+91
+0.6% +$10.4K
VTV icon
94
Vanguard Value ETF
VTV
$189B
$1.86M 0.24%
15,482
+1,701
+12% +$196K
ANSS
95
DELISTED
Ansys
ANSS
$1.83M 0.23%
7,096
-315
-4% -$74.5K
MO icon
96
Altria Group
MO
$126B
$1.82M 0.23%
36,504
+1,401
+4% +$66.1K
ORCL icon
97
Oracle
ORCL
$336B
$1.81M 0.23%
34,141
+3,677
+12% +$202K
PM icon
98
Philip Morris
PM
$314B
$1.79M 0.23%
21,018
+5,396
+35% +$445K
UNP icon
99
Union Pacific
UNP
$173B
$1.78M 0.23%
9,841
-217
-2% -$37.1K
ITW icon
100
Illinois Tool Works
ITW
$84B
$1.78M 0.23%
9,905
+453
+5% +$76.8K
2 3
4
5 6

Similar funds

SIM
Sadoff Investment Management Milwaukee, Wisconsin $1.28B AUM 6.95% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
MCM
Maryland Capital Management Towson, Maryland $1.2B AUM 18.21% 1-Year Est. Return
ACP
Ashfield Capital Partners San Francisco, California $1.19B AUM 14.56% 1-Year Est. Return
DWM
Doyle Wealth Management St. Petersburg, Florida $1.16B AUM 9.32% 1-Year Est. Return
H6H
Hightower 6M Holding Wichita, Kansas $1.11B AUM

Corient Capital Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Corient Capital Partners held 498 positions worth $787M, up 11% from $706M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Corient Capital Partners deployed $26.5M of net new capital in Q4 2019, opening 39 new positions and adding to 268 existing holdings. Its largest new stake was Huntington Bancshares: 74,119 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 Growth ETF, an estimated $1.15M trimmed.

  • Corient Capital Partners's largest Q4 2019 buy was Huntington Bancshares: 74,119 shares worth $1.12M.
  • Corient Capital Partners added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.01M increase.
  • Corient Capital Partners's biggest Q4 2019 reduction was Vanguard S&P 500 Growth ETF, cutting an estimated $1.15M.
  • Corient Capital Partners fully exited Celgene Corp in Q4 2019, selling an estimated $1.97M.
  • Corient Capital Partners's ten largest holdings make up 27% of its $787M portfolio in Q4 2019.
  • Corient Capital Partners opened 39 new positions and closed 31 in Q4 2019.
  • Corient Capital Partners's portfolio value rose 11% quarter-over-quarter to $787M.

Based on Corient Capital Partners's 13F filing for Q4 2019, filed 4 Feb 2020.